D, R., D, S., L, C., K, G., R, W., & S, T. (2024). Remdesivir and molnupiravir had comparable efficacy in lung transplant recipients with mild-to-moderate COVID-19: A single center experience. Frontiers in transplantation, 3, 1408289. https://doi.org/10.3389/frtra.2024.1408289
Chicago Style (17th ed.) CitationD, Razia, Sindu D, Cherrier L, Grief K, Walia R, and Tokman S. "Remdesivir and Molnupiravir Had Comparable Efficacy in Lung Transplant Recipients with Mild-to-moderate COVID-19: A Single Center Experience." Frontiers in Transplantation 3 (2024): 1408289. https://doi.org/10.3389/frtra.2024.1408289.
MLA (9th ed.) CitationD, Razia, et al. "Remdesivir and Molnupiravir Had Comparable Efficacy in Lung Transplant Recipients with Mild-to-moderate COVID-19: A Single Center Experience." Frontiers in Transplantation, vol. 3, 2024, p. 1408289, https://doi.org/10.3389/frtra.2024.1408289.